Pharsight

ACERTA PHARMA BV PATENTS FACING OPPOSITIONS

Top patents of ACERTA PHARMA BV facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3954690B1 05 Apr, 2023 Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide Jul, 2036 1
EP3179991B1 06 Oct, 2021 Therapeutic Combinations Of A Btk Inhibitor, A Pi3K Inhibitor, A Jak-2 Inhibitor, And/Or A Bcl-2 Inhibitor Aug, 2035 1
EP3317281B1 22 Apr, 2020 Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1 -(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide Jul, 2036 1